Wanbury Limited (NSE:WANBURY)
India · Delayed Price · Currency is INR 338.40
-1.50 (-0.44%)
Jul 21, 2026, 3:30 PM IST
Wanbury Market Cap
Wanbury has a market cap or net worth of 11.86 billion as of July 21, 2026. Its market cap has increased by 34.13% in one year.
Market Cap
11.86B
Enterprise Value
14.03B
Revenue
6.50B
Ranking
n/a
PE Ratio
17.93
Stock Price
338.40
ChartMarket Cap Chart
Since February 7, 2005, Wanbury's market cap has increased from 1.77B to 11.86B, an increase of 570.79%. That is a compound annual growth rate of 9.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 11.86B | 49.61% |
| Dec 31, 2025 | 7.93B | -17.28% |
| Dec 31, 2024 | 9.58B | 121.65% |
| Dec 29, 2023 | 4.32B | 169.44% |
| Dec 30, 2022 | 1.60B | -40.72% |
| Dec 31, 2021 | 2.71B | 135.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 47.30B |
| Solara Active Pharma Sciences | 27.50B |
| Indoco Remedies | 22.84B |
| Beta Drugs | 22.50B |
| Ind-Swift Laboratories | 20.07B |
| Sakar Healthcare | 19.53B |
| Windlas Biotech | 17.42B |
| Jagsonpal Pharmaceuticals | 15.04B |